Stephanie Hardiman is a Birmingham, Alabama based nurse practitioner. Active license number of Stephanie Hardiman is 1-128585 for Acute Care in Alabama. Her current practice location is 619 19th St S, Birmingham. Patients can reach her at 205-934-4011. Stephanie Hardiman is CRNP and her NPI number (Unique professional ID assigned by NPPES) is 1316615347. Stephanie Hardiman has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Stephanie Hardiman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1316615347
NPI Enumeration Date:
03 Sep, 2021
NPI Last Update On:
05 Nov, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Stephanie Hardiman are as mentioned below.
License Number
Specialization
State
Status
1-128585
Acute Care
Alabama
Primary
1-128585
Registered Nurse
Alabama
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Stephanie Hardiman Po Box 55310, Birmingham, Alabama
Zip:
35255-5310
Patients can reach Stephanie Hardiman at 619 19th St S, Birmingham, Alabama or can call to book an appointment on 205-934-4011.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.